In August 2015 the Federal Economic Competition Commission (COFECE) approved a concentration between Dutch fund Moench Coöperatif, UA and one of the major pharmaceutical product distributors in Mexico, Marzam, through which the former acquired control over the latter. The concentration was approved without commitments, as the COFECE was advised that Moench Coöperatif did not participate in the same market as Marzam and thus that there was no overlap between the agents involved.

On 17 July 2018 the Federal Competition Commission (FECC) issued its Competition Agenda for Public Procurement, in which it presented its findings regarding competition issues that arise during the public procurement process. In the agenda, the FECC also proposed certain courses of action (both administrative and legislative) to promote effective competition in public procurement.

On December 8 2016 the First Collegiate Tribunal on Administrative Matters Specialised in Economic Competition, Broadcasting and Telecommunications recognised the concept of attorney-client privilege and the attorney-client work product doctrine in an antitrust context for the first time (for further details please see "Courts recognise attorney-client privilege in antitrust matter for first time"). However, the tribunal's ruling was non-binding and could be used by specialised judges only as a guide.

In January 2017 the Federal Economic Competition Commission (FECC) issued its Annual Working Plan. In it, the FECC recognised that one of its strategic goals is to communicate to economic agents how anti-competitive practices will be investigated and which actions agents may adopt to prevent potential risks. In particular, the FECC declared that one of its goals for 2017 would be to launch a project to develop guidelines for the analysis of collaboration agreements between competitors. According to the FECC, this project will: l clarify key concepts on the subject; l collect best practices on the analysis of collaboration agreements among competitors; l indicate specific criteria to identify the activities that should be investigated; and l highlight collaboration agreements that may be considered collusive.